Pharmaceutical News

RSS

Individual hypertensive responses to antibiotics may vary depending on genetic makeup and gut bacteria

Individual variations in genetic makeup and gut bacteria may explain the different effects of antibiotics on blood pressure, a new rat study suggests. The findings are published ahead of print in Physiological Genomics.

23 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

PETA reports show that animal research failed to benefit human health

Animal research has failed to benefit human health, wasted limited public research funds, misled clinicians, and harmed countless animals unnecessarily, finds a new report by PETA scientists Emily Trunnell, Ph.D., and Frances Cheng, Ph.D.

23 Aug 2018

FDA approves first drug for treatment of rare disease affecting the cornea

The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).

23 Aug 2018

Common ADHD drug may cause adverse psychotic side effects

In the scientific article recently published in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, Erica Ramstad and others reviewed the existing evidence between various psychotic symptoms such as hallucinations, problems with concentration or anxiety with methylphenidate, a drug commonly prescribed as a treatment for attention deficit hyperactivity disorder and narcolepsy.

22 Aug 2018

FDA release Pilot COA Compendium to promote patient-focused drug development

Value in Health, the official journal of ISPOR, announced today the publication of a scoping review of the US Food and Drug Administration Pilot Clinical Outcome Assessment Compendium.

22 Aug 2018

Groundbreaking study finds certain brain disorders are genetically related

A large-scale, global study conducted by the Brainstorm Consortium has shown that certain brain disorders are genetically related.

22 Aug 2018

Simple paper-based test identifies falsified and substandard antibiotics

Antibiotics - medicines that treat bacterial infections - have saved millions of lives worldwide since their discovery in the early 20th century.

22 Aug 2018

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Agilent Technologies Inc. today announced that the U.S. Food and Drug Administration has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma.

22 Aug 2018

Researchers explore use of antipsychotic medications in older adults following heart surgery

Delirium is the medical term for an abrupt, rapid change in mental function that goes well beyond the typical forgetfulness of aging.

21 Aug 2018

Study may fuel need for effective drug testing in hospital emergency departments

At a time when drug overdoses are becoming more prevalent and lethal, a new report provides a snapshot of regional illicit drug use and, for the first time, highlights the complexity of detecting and treating patients at hospital emergency departments for a severe drug-related event.

21 Aug 2018

Scientists discover peptides that can be used as new antibiotic candidates

The human body produces many antimicrobial peptides that help the immune system fend off infection. Scientists hoping to harness these peptides as potential antibiotics have now discovered that other peptides in the human body can also have potent antimicrobial effects, expanding the pool of new antibiotic candidates.

21 Aug 2018

Research provides drug developers with much needed insight into serotonin receptor

Serotonin, known as the "happiness" neurotransmitter, is a chemical found in the body responsible for feelings of well-being. But serotonin isn't the only chemical that binds to the 13 serotonin receptors found on the surface of cells. Far from it. Many approved drugs also bind to serotonin receptors.

21 Aug 2018

RxBenefits introduces new tailored and flexible approach to managing hospital pharmacy benefits

RxBenefits, a full-service pharmacy benefits advisory firm, is pleased to introduce its latest innovation, a tailored and flexible approach to managing hospital pharmacy benefits.

21 Aug 2018

New proposal aims to improve drug harm assessment process

A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.

20 Aug 2018

Yale researchers identify racial disparities in prescribing opioids for chronic pain

Yale researchers have identified racial disparities in the treatment of patients who are prescribed opioids for chronic pain.

20 Aug 2018

Unique pain program helps surgical patients wean off opioids safely and effectively

A unique pain program is helping complex surgical patients wean off opioids safely and effectively, while offering alternative ways to cope with their pain and improve how they function.

20 Aug 2018

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.

20 Aug 2018

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour BioMed today announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. to develop and commercialize A167, an anti-PD-L1 antibody in Phase 2 clinical development, worldwide outside of the Greater China region.

20 Aug 2018

URI professor develops simpler and quicker method for detecting impurity in heparin

In 2008, a contaminant eluded the quality safeguards in the pharmaceutical industry and infiltrated a large portion of the supply of the popular blood thinner heparin, sickening hundreds and killing about 100 in the U.S.

19 Aug 2018

Pharmaceutical News

Individual hypertensive responses to antibiotics may vary depending on genetic makeup and gut bacteria

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

PETA reports show that animal research failed to benefit human health

FDA approves first drug for treatment of rare disease affecting the cornea

Common ADHD drug may cause adverse psychotic side effects

FDA release Pilot COA Compendium to promote patient-focused drug development

Groundbreaking study finds certain brain disorders are genetically related

Simple paper-based test identifies falsified and substandard antibiotics

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Researchers explore use of antipsychotic medications in older adults following heart surgery

Study may fuel need for effective drug testing in hospital emergency departments

Scientists discover peptides that can be used as new antibiotic candidates

Research provides drug developers with much needed insight into serotonin receptor

RxBenefits introduces new tailored and flexible approach to managing hospital pharmacy benefits

New proposal aims to improve drug harm assessment process

Yale researchers identify racial disparities in prescribing opioids for chronic pain

Unique pain program helps surgical patients wean off opioids safely and effectively

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

URI professor develops simpler and quicker method for detecting impurity in heparin

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News